A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

NCT01465529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: OligoG CF-5/20
DRUG: Saline

Sponsor

AlgiPharma AS